Exhibit 1
Transactions in the Securities of the Issuer Since the Filing of the Schedule 13D
| Nature of the Transaction | Amount of Securities Purchased/(Sold) | Price ($) | Date of Purchase/Sale |
PHILOTIMO FUND, LP
| Purchase of Common Stock | 89,435 | 2.9761 | 01/10/2025 |
| Purchase of Common Stock | 4,548 | 2.9935 | 01/13/2025 |
| Purchase of Common Stock | 6,017 | 2.9976 | 01/14/2025 |
| Purchase of Common Stock | 67,193 | 2.9606 | 01/17/2025 |
| Purchase of Common Stock | 5,513 | 2.9500 | 01/21/2025 |
| Purchase of Common Stock | 57,500 | 2.9492 | 01/22/2025 |
| Purchase of Common Stock | 71,647 | 2.9338 | 01/23/2025 |
KANEN WEALTH MANAGEMENT, LLC (through the managed accounts)
| Purchase of Common Stock | 23,000 | 2.95951 | 01/15/2025 |
| Purchase of Common Stock | 68,019 | 2.95902 | 01/24/2025 |
DAVID L. KANEN
| Purchase of Common Stock | 3,800 | 2.95951 | 01/15/2025 |
1 The reported price represents a weighted average sale price. The range of prices at which common stock was sold was $2.95 to $2.96 per share. The Reporting Person undertakes to provide to the Staff, the Issuer or a security holder full information regarding the number of shares sold at each separate price.
2 The reported price represents a weighted average sale price. The range of prices at which common stock was sold was $2.94 to $2.99 per share. The Reporting Person undertakes to provide to the Staff, the Issuer or a security holder full information regarding the number of shares sold at each separate price.
